Gault Cheryl 4
4 · Rapport Therapeutics, Inc. · Filed Sep 10, 2025
Insider Transaction Report
Form 4
Gault Cheryl
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-09-08$38.33/sh−5,000$191,650→ 171,928 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-08−5,000→ 110,407 totalExercise: $1.80Exp: 2033-12-05→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-09-08$1.80/sh+5,000$9,000→ 176,928 total
Footnotes (2)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.
- [F2]25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.